Previsioni del mercato europeo delle terapie per il cancro al seno fino al 2030 - Analisi regionale - per terapia farmacologica [terapia farmacologica mirata (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab e altre terapie farmacologiche target), terapia farmacologica ormonale (modulatori selettivi del recettore degli estrogeni, inibitori dell\'aromatasi, e downregolatori selettivi del recettore degli estrogeni), chemioterapia e immunoterapia/terapia biologica], tipo di cancro al seno (recettore ormonale, HER2+ e cancro al seno triplo negativo) e canale di distribuzione (farmacie ospedaliere, parafarmacie e farmacie al dettaglio e farmacie online) X

BMIRE00029748 | Pages: 106 | Pharmaceuticals | Mar 2024 | Type: Regional | Status: Published
Il mercato europeo delle terapie per il cancro al seno è stato valutato a 8.446,96 milioni di dollari nel 2022 e si prevede che raggiungerà 16.836,17 milioni di dollari entro il 2030; si stima che crescerà a un CAGR del 9,0% dal 2022 al 2030.

Il maggiore sostegno da parte di organizzazioni governative e private alimenta il mercato europeo della terapia per il cancro al seno.

I governi di vari paesi riconoscono l\'importanza di affrontare il cancro al seno e stanno attuando politiche per migliorare l’accesso a trattamenti efficaci. Molti governi e organizzazioni private hanno aumentato i finanziamenti per la ricerca e lo sviluppo di terapie per il cancro al seno, con conseguente sviluppo di farmaci e terapie innovative. L’Iniziativa della Commissione Europea sul cancro al seno (ECIBC) offre cure di base di qualità universalmente accessibili a tutti i livelli. La missione dell’ECIBC è fornire alle donne e agli operatori sanitari una consulenza imparziale e imparziale sullo screening e sulla cura basata sulla ricerca scientifica più recente. I maggiori investimenti nella ricerca hanno consentito alle aziende farmaceutiche di esplorare nuove opzioni terapeutiche e di sviluppare terapie altamente mirate ed efficaci per le pazienti affette da cancro al seno.

Diversi enti governativi in tutto il mondo stanno inoltre adottando misure per migliorare l\'accesso a questi trattamenti implementando politiche di rimborso e iniziative sanitarie che coprano il costo delle terapie per il cancro al seno per i pazienti. Ciò significa che più pazienti possono permettersi questi trattamenti e avere accesso ai più recenti progressi nella terapia del cancro al seno. Il maggiore sostegno governativo ha inoltre creato un contesto di mercato favorevole per gli operatori sanitari. Con maggiori finanziamenti e risorse disponibili, gli operatori sanitari sono in grado di offrire ai propri pazienti una gamma più ampia di opzioni terapeutiche. Ciò migliora i risultati dei pazienti e consente agli operatori sanitari di rimanere competitivi sul mercato. Nel complesso, il maggiore sostegno da parte dei governi e delle organizzazioni private alle terapie per il cancro al seno ha stimolato l’innovazione, portando a trattamenti nuovi e migliorati. Ha inoltre migliorato l’accesso a questi trattamenti, avvantaggiando un numero maggiore di pazienti. Ciò rappresenta un’opportunità significativa per la crescita del mercato europeo delle terapie per il cancro al seno poiché le aziende farmaceutiche e gli operatori sanitari continuano a investire in attività di ricerca e sviluppo e ad espandere le loro offerte per soddisfare la crescente domanda.

Panoramica del mercato europeo delle terapie per il cancro al seno

Il mercato europeo delle terapie per il cancro al seno è segmentato in Germania, Regno Unito, Francia, Italia, Spagna e resto d\'Europa. Il cancro al seno è un tipo comune di cancro nel Regno Unito. Secondo il Servizio Sanitario Nazionale (NHS), secondo i dati della Gran Bretagna a circa una donna su sette viene diagnosticato un cancro al seno durante la loro vita. Ogni anno a circa 55.000 donne viene diagnosticato il cancro al seno.

La maggiore richiesta da parte dell\'industria medica di curare i pazienti affetti da cancro al seno con nuove terapie ha portato a maggiori investimenti in ricerca e sviluppo, alimentando la crescita del mercato. Breast Cancer Now è il più grande finanziatore dedicato alla ricerca sul cancro al seno nel Regno Unito. Ad oggi ha investito 308,01 milioni di dollari (

Table of Content

 

1. Introduction

1.1 The Insight Partners Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Europe Breast Cancer Therapeutics Market - Key Industry Dynamics

4.1 Key Market Drivers

4.1.1 Growing Burden of Breast Cancer

4.1.2 Launch of Several Diagnostics and Screening Programs

4.2 Key Market Restraints

4.2.1 High Cost of Diagnosis and Treatment

4.3 Key Market Opportunities

4.3.1 Increased Support from Government and Private Organizations

4.4 Key Future Trends

4.4.1 Increasing Use of Personalized Medicine

4.5 Impact Analysis:

5. Breast Cancer Therapeutics Market - Europe Market Analysis

5.1 Europe Breast Cancer Therapeutics Market Revenue (US$ Mn), 2022 - 2030

6. Europe Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 - by Drug Therapy

6.1 Overview

6.2 Europe Breast Cancer Therapeutics Market Revenue Share, by Drug Therapy, 2022 & 2030 (%)

6.3 Targeted Drug Therapy

6.3.1 Overview

6.3.2 Targeted Drug Therapy: Europe Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

6.3.2.1 Europe Breast Cancer Therapeutics Market, by Targeted Drug Therapy, 2020-2030 (US$ Million)

6.4 Hormonal Drug Therapy

6.4.1 Overview

6.4.2 Hormonal Drug Therapy: Europe Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

6.4.2.1 Europe Breast Cancer Therapeutics Market, by Hormonal Drug Therapy, 2020-2030 (US$ Million)

6.5 Chemotherapy

6.5.1 Overview

6.5.2 Chemotherapy: Europe Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

6.6 Immunotherapy/ Biological Therapy

6.6.1 Overview

6.6.2 Immunotherapy/ Biological Therapy: Europe Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

7. Europe Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 - by Breast Cancer Type

7.1 Overview

7.2 Europe Breast Cancer Therapeutics Market Revenue Share, by Breast Cancer Type, 2022 & 2030 (%)

7.3 Hormone Receptor

7.3.1 Overview

7.3.2 Hormone Receptor: Europe Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

7.4 HER2+ (human epidermal growth factor receptor 2)

7.4.1 Overview

7.4.2 HER2+: Europe Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

7.5 Triple-Negative Breast Cancer

7.5.1 Overview

7.5.2 Triple-Negative Breast Cancer: Europe Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

8. Europe Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 - by Distribution Channel

8.1 Overview

8.2 Europe Breast Cancer Therapeutics Market Revenue Share, by Distribution Channel, 2022 & 2030 (%)

8.3 Hospital Pharmacies

8.3.1 Overview

8.3.2 Hospital Pharmacies: Europe Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

8.4 Drug Store and Retail Pharmacies

8.4.1 Overview

8.4.2 Drug Store and Retail Pharmacies: Europe Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

8.5 Online Pharmacies

8.5.1 Overview

8.5.2 Online Pharmacies: Europe Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

9. Europe Breast Cancer Therapeutics Market - Country Analysis

9.1 Europe Breast Cancer Therapeutics Market, Revenue and Forecast to 2030

9.1.1 Overview

9.1.2 Europe Breast Cancer Therapeutics Market, Breakdown, by key Country- Revenue (2022) (US$ Million)

9.1.3 Europe Breast Cancer Therapeutics Market, by Country, 2022 and 2030 (%)

9.1.3.1 UK

9.1.3.1.1 UK Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)

9.1.3.1.2 UK: Breast Cancer Therapeutics Market, by Drug Therapy, 2020-2030 (US$ Million)

9.1.3.1.2.1 UK: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020-2030 (US$ Million)

9.1.3.1.2.2 UK: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020-2030 (US$ Million)

9.1.3.1.3 UK: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020-2030 (US$ Million)

9.1.3.1.4 UK: Breast Cancer Therapeutics Market, by Distribution Channel, 2020-2030 (US$ Million)

9.1.3.2 Germany

9.1.3.2.1 Germany Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)

9.1.3.2.2 Germany: Breast Cancer Therapeutics Market, by Drug Therapy, 2020-2030 (US$ Million)

9.1.3.2.2.1 Germany: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020-2030 (US$ Million)

9.1.3.2.2.2 Germany: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020-2030 (US$ Million)

9.1.3.2.3 Germany: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020-2030 (US$ Million)

9.1.3.2.4 Germany: Breast Cancer Therapeutics Market, by Distribution Channel, 2020-2030 (US$ Million)

9.1.3.3 France

9.1.3.3.1 France Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)

9.1.3.3.2 France: Breast Cancer Therapeutics Market, by Drug Therapy, 2020-2030 (US$ Million)

9.1.3.3.2.1 France: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020-2030 (US$ Million)

9.1.3.3.2.2 France: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020-2030 (US$ Million)

9.1.3.3.3 France: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020-2030 (US$ Million)

9.1.3.3.4 France: Breast Cancer Therapeutics Market, by Distribution Channel, 2020-2030 (US$ Million)

9.1.3.4 Italy

9.1.3.4.1 Italy Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)

9.1.3.4.2 Italy: Breast Cancer Therapeutics Market, by Drug Therapy, 2020-2030 (US$ Million)

9.1.3.4.2.1 Italy: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020-2030 (US$ Million)

9.1.3.4.2.2 Italy: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020-2030 (US$ Million)

9.1.3.4.3 Italy: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020-2030 (US$ Million)

9.1.3.4.4 Italy: Breast Cancer Therapeutics Market, by Distribution Channel, 2020-2030 (US$ Million)

9.1.3.5 Spain

9.1.3.5.1 Spain Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)

9.1.3.5.2 Spain: Breast Cancer Therapeutics Market, by Drug Therapy, 2020-2030 (US$ Million)

9.1.3.5.2.1 Spain: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020-2030 (US$ Million)

9.1.3.5.2.2 Spain: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020-2030 (US$ Million)

9.1.3.5.3 Spain: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020-2030 (US$ Million)

9.1.3.5.4 Spain: Breast Cancer Therapeutics Market, by Distribution Channel, 2020-2030 (US$ Million)

9.1.3.6 Rest of Europe

9.1.3.6.1 Rest of Europe Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)

9.1.3.6.2 Rest of Europe: Breast Cancer Therapeutics Market, by Drug Therapy, 2020-2030 (US$ Million)

9.1.3.6.2.1 Rest of Europe: Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy, 2020-2030 (US$ Million)

9.1.3.6.2.2 Rest of Europe: Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy, 2020-2030 (US$ Million)

9.1.3.6.3 Rest of Europe: Breast Cancer Therapeutics Market, by Breast Cancer Type, 2020-2030 (US$ Million)

9.1.3.6.4 Rest of Europe: Breast Cancer Therapeutics Market, by Distribution Channel, 2020-2030 (US$ Million)

10. Breast Cancer Therapeutics Market-Industry Landscape

10.1 Overview

10.2 Growth Strategies in Breast Cancer Therapeutics Market

10.3 Organic Growth Strategies

10.3.1 Overview

10.4 Inorganic Growth Strategies

10.4.1 Overview

11. Company Profiles

11.1 Eli Lilly and Co

11.1.1 Key Facts

11.1.2 Business Description

11.1.3 Products and Services

11.1.4 Financial Overview

11.1.5 SWOT Analysis

11.1.6 Key Developments

11.2 Eisai Co Ltd

11.2.1 Key Facts

11.2.2 Business Description

11.2.3 Products and Services

11.2.4 Financial Overview

11.2.5 SWOT Analysis

11.2.6 Key Developments

11.3 Novartis AG

11.3.1 Key Facts

11.3.2 Business Description

11.3.3 Products and Services

11.3.4 Financial Overview

11.3.5 SWOT Analysis

11.3.6 Key Developments

11.4 AstraZeneca Plc

11.4.1 Key Facts

11.4.2 Business Description

11.4.3 Products and Services

11.4.4 Financial Overview

11.4.5 SWOT Analysis

11.4.6 Key Developments

11.5 Pfizer Inc

11.5.1 Key Facts

11.5.2 Business Description

11.5.3 Products and Services

11.5.4 Financial Overview

11.5.5 SWOT Analysis

11.5.6 Key Developments

11.6 Gilead Sciences Inc

11.6.1 Key Facts

11.6.2 Business Description

11.6.3 Products and Services

11.6.4 Financial Overview

11.6.5 SWOT Analysis

11.6.6 Key Developments

11.7 Merck & Co Inc

11.7.1 Key Facts

11.7.2 Business Description

11.7.3 Products and Services

11.7.4 Financial Overview

11.7.5 SWOT Analysis

11.7.6 Key Developments

11.8 Teva Pharmaceutical Industries Ltd

11.8.1 Key Facts

11.8.2 Business Description

11.8.3 Products and Services

11.8.4 Financial Overview

11.8.5 SWOT Analysis

11.8.6 Key Developments

11.9 Amgen Inc

11.9.1 Key Facts

11.9.2 Business Description

11.9.3 Products and Services

11.9.4 Financial Overview

11.9.5 SWOT Analysis

11.9.6 Key Developments

12. Appendix

12.1 About Us

12.2 Glossary of Terms

 

 

List of Tables

Table 1. Europe Breast Cancer Therapeutics Market Segmentation

Table 2. Europe Breast Cancer Therapeutics Market, by Targeted Drug Therapy - Revenue and Forecast to 2030 (US$ Million)

Table 3. Europe Breast Cancer Therapeutics Market, by Hormonal Drug Therapy - Revenue and Forecast to 2030 (US$ Million)

Table 4. UK Breast Cancer Therapeutics Market, by Drug Therapy - Revenue and Forecast to 2030 (US$ Million)

Table 5. UK Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy - Revenue and Forecast to 2030 (US$ Million)

Table 6. UK Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy - Revenue and Forecast to 2030 (US$ Million)

Table 7. UK Breast Cancer Therapeutics Market, by Breast Cancer Type - Revenue and Forecast to 2030 (US$ Million)

Table 8. UK Breast Cancer Therapeutics Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)

Table 9. Germany Breast Cancer Therapeutics Market, by Drug Therapy - Revenue and Forecast to 2030 (US$ Million)

Table 10. Germany Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy - Revenue and Forecast to 2030 (US$ Million)

Table 11. Germany Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy - Revenue and Forecast to 2030 (US$ Million)

Table 12. Germany Breast Cancer Therapeutics Market, by Breast Cancer Type - Revenue and Forecast to 2030 (US$ Million)

Table 13. Germany Breast Cancer Therapeutics Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)

Table 14. France Breast Cancer Therapeutics Market, by Drug Therapy - Revenue and Forecast to 2030 (US$ Million)

Table 15. France Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy - Revenue and Forecast to 2030 (US$ Million)

Table 16. France Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy - Revenue and Forecast to 2030 (US$ Million)

Table 17. France Breast Cancer Therapeutics Market, by Breast Cancer Type - Revenue and Forecast to 2030 (US$ Million)

Table 18. France Breast Cancer Therapeutics Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)

Table 19. Italy Breast Cancer Therapeutics Market, by Drug Therapy - Revenue and Forecast to 2030 (US$ Million)

Table 20. Italy Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy - Revenue and Forecast to 2030 (US$ Million)

Table 21. Italy Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy - Revenue and Forecast to 2030 (US$ Million)

Table 22. Italy Breast Cancer Therapeutics Market, by Breast Cancer Type - Revenue and Forecast to 2030 (US$ Million)

Table 23. Italy Breast Cancer Therapeutics Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)

Table 24. Spain Breast Cancer Therapeutics Market, by Drug Therapy - Revenue and Forecast to 2030 (US$ Million)

Table 25. Spain Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy - Revenue and Forecast to 2030 (US$ Million)

Table 26. Spain Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy - Revenue and Forecast to 2030 (US$ Million)

Table 27. Spain Breast Cancer Therapeutics Market, by Breast Cancer Type - Revenue and Forecast to 2030 (US$ Million)

Table 28. Spain Breast Cancer Therapeutics Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)

Table 29. Rest of Europe Breast Cancer Therapeutics Market, by Drug Therapy - Revenue and Forecast to 2030 (US$ Million)

Table 30. Rest of Europe Breast Cancer Therapeutics Market, For Targeted Drug Therapy by Drug Therapy - Revenue and Forecast to 2030 (US$ Million)

Table 31. Rest of Europe Breast Cancer Therapeutics Market, For Hormonal Drug Therapy by Drug Therapy - Revenue and Forecast to 2030 (US$ Million)

Table 32. Rest of Europe Breast Cancer Therapeutics Market, by Breast Cancer Type - Revenue and Forecast to 2030 (US$ Million)

Table 33. Rest of Europe Breast Cancer Therapeutics Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)

Table 34. Recent Organic Growth Strategies in Breast Cancer Therapeutics Market

Table 35. Recent Inorganic Growth Strategies in the Breast Cancer Therapeutics Market

Table 36. Glossary of Terms, Breast Cancer Therapeutics Market

List of Figures

Figure 1. Europe Breast Cancer Therapeutics Market Segmentation, By Country

Figure 2. Europe Breast Cancer Therapeutics Market - Key Industry Dynamics

Figure 3. Impact Analysis of Drivers and Restraints

Figure 4. Europe Breast Cancer Therapeutics Market Revenue (US$ Mn), 2022 - 2030

Figure 5. Europe Breast Cancer Therapeutics Market Revenue Share, by Drug Therapy, 2022 & 2030 (%)

Figure 6. Targeted Drug Therapy: Europe Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

Figure 7. Hormonal Drug Therapy: Europe Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

Figure 8. Chemotherapy: Europe Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

Figure 9. Immunotherapy/ Biological Therapy: Europe Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

Figure 10. Europe Breast Cancer Therapeutics Market Revenue Share, by Breast Cancer Type, 2022 & 2030 (%)

Figure 11. Hormone Receptor: Europe Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

Figure 12. HER2+: Europe Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

Figure 13. Triple-Negative Breast Cancer: Europe Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

Figure 14. Europe Breast Cancer Therapeutics Market Revenue Share, by Distribution Channel, 2022 & 2030 (%)

Figure 15. Hospital Pharmacies: Europe Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

Figure 16. Drug Store and Retail Pharmacies: Europe Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

Figure 17. Online Pharmacies: Europe Breast Cancer Therapeutics Market - Revenue and Forecast to 2030 (US$ Million)

Figure 18. Europe Breast Cancer Therapeutics Market, by Key Country - Revenue (2022) (US$ Million)

Figure 19. Europe Breast Cancer Therapeutics Market, By Key Countries, 2022 and 2030 (%)

Figure 20. UK Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)

Figure 21. Germany Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)

Figure 22. France Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)

Figure 23. Italy Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)

Figure 24. Spain Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)

Figure 25. Rest of Europe Breast Cancer Therapeutics Market Revenue and Forecast to 2030 (US$ Mn)

Figure 26. Growth Strategies in Breast Cancer Therapeutics Market

1. Eli Lilly and Co
2. Eisai Co Ltd
3. Novartis AG
4. AstraZeneca Plc
5. Pfizer Inc
6. Gilead Sciences Inc
7. Merck & Co Inc
8. Teva Pharmaceutical Industries Ltd
9. Amgen Inc

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe breast cancer therapeutics market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in Europe breast cancer therapeutics market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3550
$2840
Site License
$4550
$3640
Enterprise License
$5550
$4440